RYR2 and cardiac hypertrophy: Enhanced RyR2 function activates the CaN/ Nuclear factor of activated T-cells (NFAT) and CaN/Myocyte enhancer factor 2 (MEF2) pathways, leading to cardiac hypertrophy [25, 26].